OUR RESOURCES
Video and slides 
CRSF Asco list of publications 
Ongoing studies Management of Genitourinary Cancer Revisit ASCO
Management of Genitourinary Cancer Revisit ASCO GU - 26 March 2022
Welcome & Introduction
NAT IN MIBC IDEAL DRUG REGIMEN
IMbrave 150 Phase III trial of 1L Atezolizumab + Bevacizumab in patients with unresectable HCC
Panel Discussion - Metastatic Urothelial Carcinoma
ASCO GU 2022 Updates UC
Role of Immunotherapy in management of advanced RCC
Closing Remarks